Polymorphisms in BMP6 were independently associated with risk for sickle cell osteonecrosis [36], [37], pulmonary hypertension in sickle cell disease, [38] breast cancer growth and progression [39]. This evidence concerns the gene BMP6 and breast carcinoma.